Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pisegna

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The American Journal of Physiology|June 1, 1996
Model demonstrating respiratory mechanics for high school studentsV Chan, J Pisegna, R Rosian, et al.
Surgery|December 14, 2001
Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liverM H Chung, J Pisegna, M Spirt, et al.
Breast Cancer Research and Treatment|November 26, 1999
PACAP(6-38) is a PACAP receptor antagonist for breast cancer cellsJ Leyton, Y Gozes, J Pisegna, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2004
Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux diseaseJ Pisegna, G Holtmann, C W Howden, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Impaired renal D(1)-like and D(2)-like dopamine receptor interaction in the spontaneously hypertensive ratC A Ladines, C Zeng, L D Asico, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The American Journal of Physiology|June 1, 1996
Model demonstrating respiratory mechanics for high school studentsV Chan, J Pisegna, R Rosian, et al.
Surgery|December 14, 2001
Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liverM H Chung, J Pisegna, M Spirt, et al.
Breast Cancer Research and Treatment|November 26, 1999
PACAP(6-38) is a PACAP receptor antagonist for breast cancer cellsJ Leyton, Y Gozes, J Pisegna, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2004
Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux diseaseJ Pisegna, G Holtmann, C W Howden, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Impaired renal D(1)-like and D(2)-like dopamine receptor interaction in the spontaneously hypertensive ratC A Ladines, C Zeng, L D Asico, et al.
Pageof 1